Problem may be a case of "counting chickens before the eggs have hatched".
Promises of brilliant results from the HIV trial did not materialise - and BIT should have been aware that they would only mirror the previous phase2 trial.
No BP is going to offer funds after a trial showed little of no improvement.
Wishful thinking and the hope that some deal could be made and then putting this out as a quasi-fact, was very unprofessional.
BIT Price at posting:
2.1¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)